AbbVie Inc., US00287Y1091

AbbVie stock heads into the open after a 0.02 percent gain

Published on 09/24/2026 at 09:28 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 23, 2026, AbbVie stock was nearly unchanged at USD 265.21 after trading between USD 263.60 and USD 269.34. The S&P 500 fell 0.75 percent.

Fotorealistisches Pharma-Forschungslabor mit Petrischalen und Wissenschaftlern in Schutzkleidung
AbbVie Inc. US00287Y1091 fotorealistisches Pharma Forschungslabor mit Petrischalen Wissenschaftlern Immunologie Onkologie Biopharma, Illustration mit AI erstellt.

AbbVie stock closed at USD 265.21 on the NYSE on September 23, 2026, up 0.02 percent from the prior close. The shares outperformed the S&P 500, which fell 0.75 percent to 7,706.03 in the same session.

September 23, 2026 in numbers

AbbVie Inc. (ISIN US00287Y1091) traded between USD 263.60 and USD 269.34 on the NYSE, a session range of USD 5.74. The stock reached a new 52-week high of USD 269.34 during the session, while volume was reported at 188,800 shares.

The September 23 close was USD 4.13 below the session high and USD 1.61 above the session low. The broader US market moved lower as the S&P 500 declined 0.75 percent to 7,706.03, according to Kontan.

Dividend date on October 15, 2026

AbbVie has declared a quarterly dividend of USD 1.73 per share, with shareholders of record on October 15, 2026, according to Yahoo Finance. The dividend is scheduled for payment on November 16, 2026.

Disclaimer...

en | US00287Y1091 | ABBVIE INC. | boerse | 70175664 | bgmi